| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| P19341 | Beta-2-microglobulin; Fragment; | B2M; | NULL | 42 | dog |
| Q5CB03 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1; EC 2.4.1.135; Beta-1,3-glucuronyltransferase 1; Glucuronosyltransferase P; GlcAT-P; UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase; GlcUAT-P; | B3GAT1; | NP_001026804.1; | 335 | dog |
| Q5CAZ6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2; EC 2.4.1.135; Beta-1,3-glucuronyltransferase 2; GlcAT-D; UDP-glucuronosyltransferase S; GlcAT-S; Glucuronosyltransferase S; | B3GAT2; | NP_001013437.1; | 329 | dog |
| Q5TJE8 | Beta-1,3-galactosyltransferase 4; Beta-1,3-GalTase 4; Beta3Gal-T4; Beta3GalT4; GalT4; b3Gal-T4; EC 2.4.1.62; Gal-T2; Ganglioside galactosyltransferase; UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase; | B3GALT4; | NP_001074191.1;XP_005627127.1; | 383 | dog |
| Q6R755 | Apoptosis regulator Bcl-2; | BCL2; | NULL | 236 | dog |
| Q7YRB4 | Brain-derived neurotrophic factor; BDNF; | BDNF; | NP_001002975.1;XP_005633321.1;XP_005633322.1;XP_005633323.1; | 247 | dog |
| Q9TRY9 | Beta-galactosidase; EC 3.2.1.23; Acid beta-galactosidase; Lactase; | GLB1; | NP_001032730.1; | 668 | dog |
| O18835 | Beta-glucuronidase; EC 3.2.1.31; | GUSB; | NP_001003191.1; | 651 | dog |
| A1E2V0 | Baculoviral IAP repeat-containing protein 3; EC 6.3.2.-; | BIRC3; | NP_001074194.1;XP_005619570.1;XP_005619571.1;XP_005619572.1;XP_005619573.1;XP_005619574.1; | 604 | dog |
| Q8I009 | Baculoviral IAP repeat-containing protein 5; Apoptosis inhibitor survivin; | BIRC5; | NP_001003348.1; | 142 | dog |
| Q9BDQ5 | B1 bradykinin receptor; B1R; BK-1 receptor; | BDKRB1; | NP_001014306.1; | 350 | dog |
| P34819 | Bone morphogenetic protein 7; BMP-7; Osteogenic protein 1; OP-1; Fragment; | BMP7; | NULL | 187 | dog |
| Q9GL27 | Brachyury protein; Protein T; | T; | NP_001003092.1; | 435 | dog |
| Q95153 | Breast cancer type 1 susceptibility protein homolog; EC 6.3.2.-; | BRCA1; | NP_001013434.1; | 1878 | dog |
| Q5TJG6 | Bromodomain-containing protein 2; | BRD2; | NP_001041552.1;XP_005627105.1;XP_005627106.1; | 803 | dog |
| Q2VLG6 | Scavenger receptor cysteine-rich type 1 protein M130; CD antigen CD163; [Cleaved into: Soluble CD163 (sCD163)]; | CD163; M130; | NP_001041485.1; | 1133 | dog |
| P30992 | C5a anaphylatoxin chemotactic receptor 1; C5a anaphylatoxin chemotactic receptor; C5a-R; C5aR; CD antigen CD88; | C5AR1; C5R1; | NP_001003373.1; | 352 | dog |
| F1PAA9 | Cadherin-1; Epithelial cadherin; E-cadherin; Uvomorulin; CD antigen CD324; [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3]; | CDH1; | NP_001274054.1; | 885 | dog |
| Q865C0 | Carbonic anhydrase 6; EC 4.2.1.1; Carbonate dehydratase VI; Carbonic anhydrase VI; CA-VI; | CA6; | NP_001002999.1; | 320 | dog |
| Q9MYV1 | Calcitonin gene-related peptide 1; Alpha-type CGRP; Calcitonin gene-related peptide I; CGRP-I; | CALCA; CALC CCALCI; | XP_005633337.1;XP_005633338.1; | 128 | dog |
